In contrast, compounds such as Nusinersen, which acts upon the SMN-2 gene involved in spinal muscular atrophy, and Golodirsen, which targets DMD for Duchenne muscular dystrophy, are examples of the second mechanism class of ASOs and act through steric blocking in order to induce alternative splicing [21]. Here, SMN2 is linked to Duchenne muscular dystrophy.